CID 355584

N-(2-ethyl-3-methyl-1-phenyl-3-pyrazolin-5-ylidene)salicylamide

Structural Information

Molecular Formula
C19H19N3O2
SMILES
CCN1C(=CC(=NC(=O)C2=CC=CC=C2O)N1C3=CC=CC=C3)C
InChI
InChI=1S/C19H19N3O2/c1-3-21-14(2)13-18(22(21)15-9-5-4-6-10-15)20-19(24)16-11-7-8-12-17(16)23/h4-13,23H,3H2,1-2H3
InChIKey
VNCOWZFHARHZND-UHFFFAOYSA-N
Compound name
N-(1-ethyl-5-methyl-2-phenylpyrazol-3-ylidene)-2-hydroxybenzamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

321.14774 Da
Monoisotopic Mass

4.3
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 322.15502 177.1
[M+Na]+ 344.13696 191.5
[M+NH4]+ 339.18156 183.8
[M+K]+ 360.11090 185.9
[M-H]- 320.14046 182.1
[M+Na-2H]- 342.12241 186.1
[M]+ 321.14719 180.5
[M]- 321.14829 180.5
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.